An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence-based ...
(NYSE: PFE) today announced topline results from the Phase 3 MagnetisMM-32 study evaluating ELREXFIO ® (elranatamab) as monotherapy in adults with relapsed or refractory multiple myeloma (RRMM) who ...
My 22-year-old daughter gets sick often. She’s a nursing student and in the hospitals often for her clinicals, but she always ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results